跳至主要内容
临床试验/NCT05199480
NCT05199480已完成早期 1 期

Understanding the Impact of Cartridge-Based Electronic Cigarettes and Generated Aerosols on Cardiopulmonary Health

Virginia Commonwealth University1 个研究点 分布在 1 个国家目标入组 4 人开始时间: 2022年1月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
4
试验地点
1
主要终点
Change in Peak oxygen consumption (VO2 peak)

研究概览

简要总结

Over the last decade, e-cigarettes have become increasingly popular, due to their promotion as a healthy alternative to traditional tobacco cigarettes. However, there are large discrepancies of knowledge in understanding how these e-cigarettes affect the user's health. The overall goal of this study is to evaluate the impact of e-cigarettes usage on user's cardiopulmonary health

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • E-Cigarette group:
  • 21 years of age or older
  • Used e-cigarettes (≥3 times/week for ≥3 months)
  • Non e-cigarette group
  • ● 21 years of age or older

排除标准

  • 20 years old and younger
  • Use of cigarettes for 15 days or more in the past 60 days
  • Use of other tobacco products (cigars, hookah, smokeless) weekly or more frequently in the past 60 days
  • Use of marijuana or any illicit or prescription drugs for non-medical use weekly or more frequently in the past 60 days
  • Known allergy to propylene glycol or vegetable glycerin
  • Evidence of cardiovascular, pulmonary, renal, hepatic, metabolic, or cerebral diseases
  • Disorder or use of medication that affects cardiopulmonary health
  • Evidence of pregnancy or current nursing

研究组 & 干预措施

E-cigarette liquid type 1

Experimental

Participants will be instructed to use at least one study product daily in place of their own e-cigarettes during the intervention period.

干预措施: Tobacco flavored liquid type 1 (Drug)

E-cigarettes liquid type 2

Active Comparator

Participants will be instructed to use at least one study product daily in place of their own e-cigarettes during the intervention period.

干预措施: Tobacco flavored liquid type 2 (Drug)

结局指标

主要结局

Change in Peak oxygen consumption (VO2 peak)

时间窗: Change from baseline to 2 weeks

Participants' peak oxygen consumption (VO2 peak) will be measured using a standardized exercise capacity test performed on a stationary bike.

Change in Expiratory Volume

时间窗: Change from baseline to 2 weeks

Participants expiratory volume will be measured through spirometry using a pulmonary function device.

次要结局

  • Change in Maximal microvascular dilation(Change from baseline to 2 weeks)
  • Change in Skeletal muscle O2 utilization(Change from baseline to 2 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验